Showing 1,201 - 1,220 results of 66,977 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.53s Refine Results
  1. 1201
  2. 1202
  3. 1203

    LiCl administered via 0.5% LiCl food pellets for 4 wks decreases GFAP levels in <i>Gfap</i>-R236H/+ mice. by Christine M. LaPash Daniels (796881)

    Published 2015
    “…(E) 0.5% LiCl treatment decreased <i>Gfap</i> transcript levels relative to <i>Tbp</i> in all regions except cerebellum of R236H/+ male mice (N = 4–5 mice per group). …”
  4. 1204
  5. 1205

    miR-214 decreased the number of viable cells and induced apoptosis in HSA cell lines. by Kazuki Heishima (791938)

    Published 2015
    “…<p>(A) Cell viability was assessed by performing the MTT assay. miR-214-transfection decreased the number of viable cells in HSA cell lines and that of control EC. …”
  6. 1206
  7. 1207
  8. 1208

    Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides by Sara Ram Pedersen (843509)

    Published 2016
    “…Immunization of transgenic HLA-A*02:01/HLA-DRB1*01:01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. …”
  9. 1209
  10. 1210
  11. 1211
  12. 1212

    LiCl administered via 0.5% LiCl food pellets for 8 wks decreases GFAP levels in surviving <i>Gfap</i>-R236H/+ mice. by Christine M. LaPash Daniels (796881)

    Published 2015
    “…(D) 0.5% LiCl decreased <i>Gfap</i> promoter activity in hippocampus, cortex, brain stem, cerebellum, and cervical spinal cord of R236H/+; <i>Gfap</i>-<i>luc</i> mice (N = 3–5 cages, 4–5 mice per group). …”
  13. 1213
  14. 1214
  15. 1215
  16. 1216
  17. 1217
  18. 1218

    C2GnT1 gene knock-down results in decreased binding of cells to E-selectin. by Catherine A. St. Hill (357388)

    Published 2013
    “…Significantly fewer LS174T cells transduced with C2GnT1 shRNA and treated with a blocking anti-E-selectin mAb accumulated on E-selectin than those cells treated with an isotype control mAb, <sup>&</sup>p = 0.01. …”
  19. 1219
  20. 1220